The biotechnology company posted revenue of $2.7 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected ...
News
- Ardelyx: 3Q Earnings Snapshot
- Plus Therapeutics Announces Formation of Scientific Advisory Board
... in hematology and medical oncology at the UT Health San Antonio. ... His research interests include liposomes, lipid-core micelles, biomedical ...
- Bioprocess Validation Market Top key players @ Merck KGaA (Germany), SGS SA (Switzerland ...
... Scientific (Luxembourg), Sartorius Stedim Biotech (France), Pall Corporation (US), Cobetter Filtration Equipments Co., Ltd ... 1604 W San Antonio,.
- Harvard Bioscience: 3Q Earnings Snapshot
San Antonio was unusually dry and warm in October.... Human remains were found in a wooded area behind a Southeast Side nursing home ...
- Regenxbio: 3Q Earnings Snapshot
The biotechnology company posted revenue of $98.9 million in the period. Regenxbio shares have fallen 24% since the beginning of the year.